Provided by Tiger Fintech (Singapore) Pte. Ltd.

Liberty All-Star Equity

6.66
+0.08001.22%
Volume:486.73K
Turnover:3.23M
Market Cap:1.92B
PE:5.37
High:6.67
Open:6.60
Low:6.59
Close:6.58
Loading ...

ASX Market Update: Deepseek decimates AI-themed stocks | January 28, 2025

The Market Herald
·
28 Jan

ASX Midday Sector Update: Communication Services Stocks Rise, Real Estate Stocks Plunge

MT Newswires Live
·
28 Jan

Why Dropsuite, Monadelphous, Sigma, and Telix shares are storming higher today

MotleyFool
·
28 Jan

MKS Instruments Completes Repricing on its Secured Term Loan B USD and EUR Tranches and Makes a $100 Million Voluntary Prepayment on its Secured Term Loan B USD

GlobeNewswire
·
24 Jan

American Rare Earths Updates Shareholders

GlobeNewswire
·
23 Jan

Sarah Salih Joins State Street as Head of North America Investment Services Business

Business Wire
·
23 Jan

InflaRx Announces Participation in Guggenheim SMID Cap Biotech Conference

GlobeNewswire
·
23 Jan

Recce Pharmaceuticals Doses All Patients in Phase II Trial of RECCE® 327 Topical Gel in Acute Bacterial Skin and Skin Structure Infections

GlobeNewswire
·
22 Jan

Semtech's HL7900 5G LPWA Module Certified by Leading U.S. Carriers

Business Wire
·
21 Jan

Sequans Acquires Zurich-based ACP

Newsfile
·
21 Jan

Rhyolite Ridge Lithium-Boron Project Closes Upsized $996 Million Loan From U.S. Department of Energy to Accelerate Domestic Critical Mineral Production

Business Wire
·
18 Jan

Top Dividend Stocks To Consider In January 2025

Simply Wall St.
·
17 Jan

Digital Cyborgs and Their Rights: The Legal Side of AI Agents

CoinMarketCap
·
17 Jan

American Rare Earths Named to the 2025 OTCQX Best 50

GlobeNewswire
·
16 Jan

GearTrack Selects Sequans Monarch Module to Power Its Asset Tracking Solution

Newsfile
·
16 Jan

InflaRx Receives European Commission Approval for GOHIBIC® (vilobelimab) for the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS)

GlobeNewswire
·
16 Jan